Schedule 13G ownership disclosure

AXOVANT SCIENCES LTD

Security class unavailable · CUSIP: G0750W104

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-462272
Form type
SC 13G/A
Filer
Sio Gene Therapies Inc.
CIK
CIK 1636050
Filed
Feb 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub